Jeff DeFalco

Title: Jeff DeFalco: Innovator in Antibody Research

Introduction

Jeff DeFalco is a prominent inventor based in Foster City, CA (US). He has made significant contributions to the field of antibody research, holding a total of 2 patents. His work focuses on developing innovative solutions for diagnosing and treating tumors.

Latest Patents

One of Jeff DeFalco's latest patents is titled "Antibodies that bind tumor tissue for diagnosis and therapy." This patent provides antibodies that bind to tumor tissue through a binding interaction with an extracellular RNA-protein complex. These antibodies are utilized in methods of inducing an immune response and inhibiting tumor cell growth. Additionally, the patent outlines methods for producing such antibodies. Another notable patent is "Use of nanoexpression to interrogate antibody repertoires." This patent discloses methods and compositions for using nanoexpression to interrogate antigen specificity within antibody repertoires. It also includes an antibody display system composition comprising recombinant nucleic acid sequences that encode heavy and light chain variable region sequences.

Career Highlights

Jeff DeFalco is currently associated with Atreca, Inc., where he continues to advance his research in antibody technology. His work has the potential to significantly impact cancer diagnosis and treatment.

Collaborations

Throughout his career, Jeff has collaborated with notable colleagues, including Daniel Eric Emerling and Shaun M Lippow. These collaborations have further enriched his research and innovation in the field.

Conclusion

Jeff DeFalco is a dedicated inventor whose work in antibody research is paving the way for new diagnostic and therapeutic methods in oncology. His contributions are vital to the ongoing fight against cancer.